2019 PDA Drug Delivery of Injectables Conference

09:00 - 10:15
TRACK A3: Manufacturing/Technology: Role of Primary Packaging Components and Device/Track and Trace/Assembly
This session shows how primary packaging components can interact with the filling machines, document the process and ensure total quality control.
Moderator: Wayne Wu, President, PDA Taiwan Chapter

09:00 - 10:15
TRACK B3: Digital Health Applications Enabling Personalized Patient Care
Connected devices help patients better manage their own health and care at home, which also contributes to better adherence. This session gives examples how this can be used for monitoring and diagnostic purposes but also how the internet of things can contribute for data exchange between patients at home and healthcare providers. 
Moderator: Chi-Feng Chang, PhD, Deputy Director, BPIPO

Track A4: Manufacturing/Technology
The final step of manufacturing a drug delivery device is the assembly of the primary packaging with the device. This is a crucial step and it only is successful in terms of quality if clear specification for the primary packaging components and the filling have been considered. This session describes the testing and manufacturing steps which are necessary.
Moderator:  Wayne Wu,  President, PDA Taiwan Chapter

10:45 - 12:30
TRACK B4: Special Device Applications
This session has presentations which deal with special topics. One is about handling of highly potent drugs and the other presentation covers the whole development process of a syringe for ophthalmic use. The very challenging quality requirements and their technical implementation are described. The session ends with a regulatory related topic addressing essential performance requirements and control strategy for combination products.
Moderator: Shih-Chong Tsai, PhD, Executive Director, Institute of Biologics, Development Center for Biotechnology

13:30 - 15:30
P3: Digital Health
Healthcare costs are increasing, and people look for ways to reduce costs by integrating digital health technologies into current healthcare infrastructure. This session gives a broader and global perspective of digital health. Highlighting efforts of governments but also showing opportunities for the healthcare systems and advantages for patients.
Moderator: Ed Deng, Co-Founder & CEO, Health2Sync

16:00 - 17:30
P4: Panel Discussion: Future of Drug Delivery and Digitalization in Health Care in Asia
In many Asian countries, the patients still receive their injectables from healthcare professionals and the home care treatment does not yet play a significant role. But healthcare costs and improved patient care will lead to developments where patients receive user friendly application systems like autoinjectors, pens and wearables. In addition, concepts of microelectronics and digitalization in combination with the pharmaceutical product will be play a role. There will be opportunities to directly receive data from the patient and have a direct access to therapy and diagnostic data from the patient. The technologies by itself are there and the potential advantages for patient management and health care costs are given or at least can be estimated. This panel discussion wants to address the dynamic of this process and the implications on patient and healthcare system. What are the real advantages? What is the impact on the health care system? What will be the drivers? What will the situation be in 10-30 years from today?
Moderator: Herbert Chung-Hsiun Wu, PhD, Co-Chair, BPIPO, Markus Bauss, Co-Chair, SHL Connect and Marc Rohrschneider, Novartis